Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy
Acta Cirúrgica Brasileira · 2023
DOI: 10.1590/acb385023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cirúrgica Brasileira, 2023. Verfasst von Yiyi Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shunde Hospital of Southern Medical University - Department of Gestroenterology - Foshan - China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shunde Hospital of Southern Medical University - Department of Gestroenterology - Foshan - China.
- Shunde Hospital of Southern Medical University - Department of VIP Medical Center - Foshan - China.
Zitieren
APA
Hu, Y., Peng, X., Du, G., Zhai, Y., Xiong, X., & Luo, X. (2023). Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy. Acta Cirúrgica Brasileira. https://doi.org/10.1590/acb385023
Vancouver
Hu Y, Peng X, Du G, Zhai Y, Xiong X, Luo X. Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy. Acta Cirúrgica Brasileira. 2023. doi:10.1590/acb385023
BibTeX
@article{Hu2023,
author = {Hu, Yiyi and Peng, Xuetao and Du, Guoping and Zhai, Yingji and Xiong, Xingbo and Luo, Xiaoliang},
title = {Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy},
journal = {Acta Cirúrgica Brasileira},
year = {2023},
doi = {10.1590/acb385023}
}
EUVIMED